Hydromorphone Immediate-Release Oral Presentations Shortage

• • Dilaudid oral immediate release tablet, Rhodes, 2 mg, bottle, 100 count, NDC 42858-0122-01
  • Dilaudid oral immediate release tablet, Rhodes, 4 mg, bottle, 100 count, NDC 42858-0234-01
  • Dilaudid oral immediate release tablet, Rhodes, 4 mg, bottle, 500 count, NDC 42858-0234-50
  • Dilaudid oral immediate release tablet, Rhodes, 8 mg, bottle, 100 count, NDC 42858-0338-01
  • Dilaudid oral solution, Rhodes, 1 mg/mL, 473 mL bottle, NDC 42858-0416-16
  • Hydromorphone Hydrochloride oral immediate release tablet, Mallinckrodt, 2 mg, bottle, 100 count, NDC 00406-3243-01
  • Hydromorphone Hydrochloride oral immediate release tablet, Mallinckrodt, 4 mg, bottle, 100 count, NDC 00406-3244-01
  • Hydromorphone Hydrochloride oral immediate release tablet, Mallinckrodt, 8 mg, bottle, 100 count, NDC 00406-3249-01
  • Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 2 mg, bottle, 100 count, NDC 42858-0301-01
  • Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 2 mg, unit-dose blister pack, 100 count, NDC 42858-0301-25
  • Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 4 mg, bottle, 100 count, NDC 42858-0302-01
  • Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 4 mg, unit-dose blister pack, 100 count, NDC 42858-0302-25
  • Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 8 mg, bottle, 100 count, NDC 42858-0303-01
  • Hydromorphone Hydrochloride oral solution, Rhodes, 1 mg/mL, 473 mL bottle, NDC 42858-0304-16
  • Hydromorphone Hydrochloride oral tablet, Rhodes, bottle, 500 count, NDC 42858-0302-50

• • Rhodes has hydromorphone tablets on back order due to DEA quota/active ingredient exhaustion.
  • Rhodes did not provide a reason for the shortage of Dilaudid oral presentations.
  • Mallinckrodt is actively manufacturing hydromorphone tablets. Wholesalers may be allocating product.

• • There is insufficient supply for usual ordering.

Estimated Resupply Dates

• • Mallinckrodt is actively manufacturing hydromorphone tablets. Wholesalers are allocating all presentations.
  • Rhodes has hydromorphone 2 mg tablets and 4 mg tablets in unit-dose packaging and hydromorphone 1 mg/mL oral solution on back order and the company cannot estimate a resupply date. Hydromorphone 2 mg tablets, 4 mg tablets in 100 count and 500 count bottles, and 8 mg tablets in 100 count bottles on back order and the company estimates a release date in mid-to-late-May 2024.
  • Rhodes has all Dilaudid 2 mg , 4 mg, and 8 mg tablets on back order and the company cannot estimate a release date. The Dilaudid 1 mg/mL oral solution is available in limited quantities.